When the human B cell line derived from B cell lymphoma was treated with the TBK1 inhibitors, BACH1 protein amount was increased (Figure 5C), suggesting the universality of BACH1 protein regulation by TBK1. This evidence concerns the gene TBK1 and B-cell non-Hodgkin lymphoma.